Novo Nordisk Follows Lilly To Lower-Priced Insulin

 
• By Dave Wallace

Novo Nordisk will launch US authorized generics of its NovoLog and NovoLog Mix at half the price of the brands from the start of 2020.

Insulin
A drop in the price of insulin aspart will result from Novo Nordisk’s authorized generics • Source: Shutterstock

More from Drug Pricing

More from Policy & Regulation